Back
Repligen Vs. West Pharmaceutical Services Industry Stock Comparison
Buy
52
RGEN
Repligen
Last Price:
139.51
Seasonality Move:
9.8%
Sell
49
WST
West Pharmaceutical Services
Last Price:
314.70
Seasonality Move:
6.17%
Buy
52
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $139.67. The Score for RGEN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
West Pharmaceutical Services (WST)
is a Sell
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $314.77. The Score for WST is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- WST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RGEN Stock Price Chart
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $314.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WST is experiencing selling pressure, which indicates risk of future bearish movement.
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.46 | Sell |
| Relative Strength Index (14 RSI): | 49.85 | Sell |
| Chaikin Money Flow: | 213158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.03 - 144.23) | Buy |
| Bollinger Bands (100): | (127.73 - 152.95) | Sell |
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.26 | Buy |
| Relative Strength Index (14 RSI): | 56.66 | Buy |
| Chaikin Money Flow: | -321630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (287.67 - 311.57) | Buy |
| Bollinger Bands (100): | (293.24 - 321.84) | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.46 | Buy |
| 20-day SMA: | 138.86 | Buy |
| 50-day SMA: | 141.91 | Sell |
| 200-day SMA: | 159.6 | Sell |
| 8-day EMA: | 137.82 | Buy |
| 20-day EMA: | 139.08 | Buy |
| 50-day EMA: | 141.54 | Sell |
| 200-day EMA: | 152.14 | Sell |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 314.95 | Sell |
| 20-day SMA: | 299.84 | Buy |
| 50-day SMA: | 301.98 | Buy |
| 200-day SMA: | 337.32 | Sell |
| 8-day EMA: | 310.86 | Buy |
| 20-day EMA: | 305.03 | Buy |
| 50-day EMA: | 303.78 | Buy |
| 200-day EMA: | 325.18 | Sell |
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.38 per share.
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.36 per share, and an increase next year of $0.87 per share.
Repligen Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
West Pharmaceutical Services Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||